Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent advancements in the development of bioactive pyrazoline derivatives
Bhupender Nehra, Sandeep Rulhania, Shalini Jaswal, et al.
European Journal of Medicinal Chemistry (2020) Vol. 205, pp. 112666-112666
Closed Access | Times Cited: 107

Showing 1-25 of 107 citing articles:

Pyrazole and pyrazoline derivatives as antimalarial agents: A key review
Lekkala Ravindar, Siti Aishah Hasbullah, K.P. Rakesh, et al.
European Journal of Pharmaceutical Sciences (2022) Vol. 183, pp. 106365-106365
Open Access | Times Cited: 64
A comprehensive review on pyrazoline based heterocyclic hybrids as potent anticancer agents
Kashif Haider, Mohd Shafeeque, Shaikh Yahya, et al.
European Journal of Medicinal Chemistry Reports (2022) Vol. 5, pp. 100042-100042
Open Access | Times Cited: 42
Novel pyrazoline linked acyl thiourea pharmacophores as antimicrobial, urease, amylase and α-glucosidase inhibitors: design, synthesis, SAR and molecular docking studies
Aamer Saeed, Atteeque Ahmed, Main Bilal Haider, et al.
RSC Advances (2024) Vol. 14, Iss. 2, pp. 1018-1033
Open Access | Times Cited: 9
Identification of a new class of potent aldose reductase inhibitors: Design, microwave-assisted synthesis, in vitro and in silico evaluation of 2-pyrazolines
Belgin Sever, Mehlika Dilek Altıntop, Yeliz Demir, et al.
Chemico-Biological Interactions (2021) Vol. 345, pp. 109576-109576
Closed Access | Times Cited: 50
Pyrazoline Containing Compounds as Therapeutic Targets for Neurodegenerative Disorders
Mohamed Jawed Ahsan, Amena Ali, Abuzer Ali, et al.
ACS Omega (2022) Vol. 7, Iss. 43, pp. 38207-38245
Open Access | Times Cited: 36
Synthesis and Evaluation of 1,3,5-Triaryl-2-Pyrazoline Derivatives as Potent Dual Inhibitors of Urease and α-Glucosidase Together with Their Cytotoxic, Molecular Modeling and Drug-Likeness Studies
Rabia Mehmood, Amina Sadiq, Reem I. Alsantali, et al.
ACS Omega (2022) Vol. 7, Iss. 4, pp. 3775-3795
Open Access | Times Cited: 34
Design and Synthesis of Carbothioamide/Carboxamide-Based Pyrazoline Analogs as Potential Anticancer Agents: Apoptosis, Molecular Docking, ADME Assay, and DNA Binding Studies
Manish Rana, Md Imam Faizan, Sajad Hussain Dar, et al.
ACS Omega (2022) Vol. 7, Iss. 26, pp. 22639-22656
Open Access | Times Cited: 31
Synthesis and Antiproliferative Activity of a New Series of Mono- and Bis(dimethylpyrazolyl)-s-triazine Derivatives Targeting EGFR/PI3K/AKT/mTOR Signaling Cascades
Ihab Shawish, Assem Barakat, Ali Aldalbahi, et al.
ACS Omega (2022) Vol. 7, Iss. 28, pp. 24858-24870
Open Access | Times Cited: 30
The Synthesis, In Vitro Bio-Evaluation, and In Silico Molecular Docking Studies of Pyrazoline–Thiazole Hybrid Analogues as Promising Anti-α-Glucosidase and Anti-Urease Agents
Yousaf Khan, Shoaib Khan, Rafaqat Hussain, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1650-1650
Open Access | Times Cited: 15
Recent advances in the synthesis of pyrazoline derivatives from chalcones as potent pharmacological agents: A comprehensive review
Chandra Shekhar Yadav, Iqbal Azad, Abdul Rahman Khan, et al.
Results in Chemistry (2024) Vol. 7, pp. 101326-101326
Open Access | Times Cited: 5
Exploring pyrazolines as potential inhibitors of NSP3-macrodomain of SARS-CoV-2: synthesis and in silico analysis
R. R. Joshi, Harsh Gaikwad, Bhavana Soge, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Organocatalytic synthesis of novel pyrazoline and pyrimidine derivatives as potent thymidine kinase inhibitors targeting Staphylococcus aureus
Mohammed Issa Alahmdi, Avijit Bhakta, Meshari A. Alsharif, et al.
Journal of Molecular Structure (2025) Vol. 1328, pp. 141427-141427
Closed Access
Synthetic aspects, structural insights and pharmacological potential of pyrazole derivatives: an overview
Regina Menezes, K. Subrahmanya Bhat
Deleted Journal (2025) Vol. 7, Iss. 2
Open Access
Sequential DNA-Encoded Building Block Fusion for the Construction of Polysubstituted Pyrazoline Core Libraries
Juan Zhang, Xianfeng Li, Haimei Wei, et al.
Organic Letters (2021) Vol. 23, Iss. 21, pp. 8429-8433
Closed Access | Times Cited: 33
Synthesis, characterization, docking study and biological evaluation of new chalcone, pyrazoline, and pyrimidine derivatives as potent antimalarial compounds
Mohammad Murwih Alidmat, Melati Khairuddean, N Norman, et al.
Arabian Journal of Chemistry (2021) Vol. 14, Iss. 9, pp. 103304-103304
Open Access | Times Cited: 32
Recent advancements and developments in search of anti-tuberculosis agents: A quinquennial update and future directions
Tejas M. Dhameliya, Kaushikkumar A. Bhakhar, Normi D. Gajjar, et al.
Journal of Molecular Structure (2021) Vol. 1248, pp. 131473-131473
Closed Access | Times Cited: 32
Strategies and Methods for the Synthesis of 2‐Pyrazolines: Recent Developments (2012–2022)
Dimitris Matiadis
Advanced Synthesis & Catalysis (2023) Vol. 365, Iss. 12, pp. 1934-1969
Open Access | Times Cited: 13
Design and synthesis of isoniazid-based pyrazolines as potential inhibitors of Mycobacterium tuberculosis with promising radical scavenging action: In-vitro and in-silico evaluations
Jyoti Rasgania, Renu Gavadia, Mandira Varma‐Basil, et al.
Journal of Molecular Structure (2023) Vol. 1295, pp. 136657-136657
Closed Access | Times Cited: 12
Benzothiazole a privileged scaffold for Cutting-Edges anticancer agents: Exploring drug design, structure-activity relationship, and docking studies
I. Aayishamma, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116831-116831
Closed Access | Times Cited: 4
Investigation of indole functionalized pyrazoles and oxadiazoles as anti-inflammatory agents: Synthesis, in-vivo, in-vitro and in-silico analysis
Devendra Kumar, Ravi Kumar, Shelly Pathania, et al.
Bioorganic Chemistry (2021) Vol. 114, pp. 105068-105068
Closed Access | Times Cited: 31
Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights
Tarfah Al‐Warhi, Ahmed M. El Kerdawy, Mohamed A. Said, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 1457-1471
Open Access | Times Cited: 20
The medicinal perspective of 2,4‐thiazolidinediones based ligands as antimicrobial, antitumor and antidiabetic agents: A review
Kumari Kajal, Gurpreet Singh, Tathagata Pradhan, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 9
Closed Access | Times Cited: 18
Photocatalytic three-component radical cascade: a general route to heterocyclic-substituted alkyl sulfones
Jian-Qiang Chen, Nana Liu, Qian Hu, et al.
Organic Chemistry Frontiers (2021) Vol. 8, Iss. 19, pp. 5316-5321
Closed Access | Times Cited: 24
De Novo Design of Imidazopyridine-Tethered Pyrazolines That Target Phosphorylation of STAT3 in Human Breast Cancer Cells
Akshay Ravish, Rashmi Shivakumar, Xi Zhang, et al.
Bioengineering (2023) Vol. 10, Iss. 2, pp. 159-159
Open Access | Times Cited: 9
Fluorinated pyrazoline-linked axial silicon phthalocyanine, alpha (α) and beta (β) zinc phthalocyanines on photophysicochemical properties
Halise Yalazan, İpek Ömeroğlu, Gonca Çelik, et al.
Inorganica Chimica Acta (2023) Vol. 551, pp. 121480-121480
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top